Wedbush Reaffirms Underperform on Sequenom (SQNM); Current Market Cap Prices In Significant Diagnostics Success
Tweet Send to a Friend
Wedbush Morgan reaffirms their Underperform rating on Sequenom (Nasdaq: SQNM), and keeps a $0.50 price target.
Wedbush notes that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush notes that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
